Thanh C Bui1,2, Bárbara Piñeiro2, Damon J Vidrine3, David W Wetter4, Summer G Frank-Pearce2,5, Jennifer I Vidrine3. 1. Department of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK. 2. Oklahoma Tobacco Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK. 3. Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL. 4. Huntsman Cancer Institute and the Department of Population Health Sciences, University of Utah, Salt Lake City, UT. 5. Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Abstract
INTRODUCTION: Given that people living with HIV (PLWH) are disproportionately burdened by tobacco-related morbidity and mortality, it is critically important to understand the degree to which evidence-based cessation interventions are utilized by and are effective among PLWH. AIMS AND METHODS: This secondary data analysis aimed to examine differences in Quitline treatment enrollment and 6-month cessation outcomes among smokers seeking care at 1 HIV clinic and 12 non-HIV clinics that were part of a large healthcare system in the greater Houston, Texas metropolitan area, United States. Data were from a 34-month (April 2013-February 2016) one-group implementation trial that evaluated the Ask-Advise-Connect (AAC) approach to linking smokers with Quitline treatment. Primary outcomes included (1) treatment enrollment and (2) 6-month self-reported and biochemically confirmed abstinence. RESULTS: The smoking status of 218 915 unique patients was recorded in the electronic health record; 5285 (2.7%) of these patients were seen at the HIV clinic where the smoking prevalence was 45.9%; smoking prevalence at the non-HIV clinics was 17.9%. The proportion of identified smokers who enrolled in treatment was 10.8% at the HIV clinic and 11.8% at the non-HIV clinics. The self-reported abstinence rate was 18.7% among HIV clinic patients and 16.5% among non-HIV clinic patients. Biochemically confirmed abstinence was lower at 4.2% and 4.5%, respectively (all ps > .05). CONCLUSIONS: AAC resulted in rates of Quitline treatment enrollment and abstinence rates that were comparable among patients seen at an HIV clinic and non-HIV clinics. Findings suggest that AAC should be considered for widespread implementation in HIV clinics. IMPLICATIONS: PLWH were as likely as other patients to enroll in evidence-based tobacco cessation treatment when it was offered in the context of a primary care visit. Cessation outcomes were also comparable. Therefore, standard care for PLWH should include routine screening for smoking status and referrals to cessation treatment.
INTRODUCTION: Given that people living with HIV (PLWH) are disproportionately burdened by tobacco-related morbidity and mortality, it is critically important to understand the degree to which evidence-based cessation interventions are utilized by and are effective among PLWH. AIMS AND METHODS: This secondary data analysis aimed to examine differences in Quitline treatment enrollment and 6-month cessation outcomes among smokers seeking care at 1 HIV clinic and 12 non-HIV clinics that were part of a large healthcare system in the greater Houston, Texas metropolitan area, United States. Data were from a 34-month (April 2013-February 2016) one-group implementation trial that evaluated the Ask-Advise-Connect (AAC) approach to linking smokers with Quitline treatment. Primary outcomes included (1) treatment enrollment and (2) 6-month self-reported and biochemically confirmed abstinence. RESULTS: The smoking status of 218 915 unique patients was recorded in the electronic health record; 5285 (2.7%) of these patients were seen at the HIV clinic where the smoking prevalence was 45.9%; smoking prevalence at the non-HIV clinics was 17.9%. The proportion of identified smokers who enrolled in treatment was 10.8% at the HIV clinic and 11.8% at the non-HIV clinics. The self-reported abstinence rate was 18.7% among HIV clinic patients and 16.5% among non-HIV clinic patients. Biochemically confirmed abstinence was lower at 4.2% and 4.5%, respectively (all ps > .05). CONCLUSIONS: AAC resulted in rates of Quitline treatment enrollment and abstinence rates that were comparable among patients seen at an HIV clinic and non-HIV clinics. Findings suggest that AAC should be considered for widespread implementation in HIV clinics. IMPLICATIONS: PLWH were as likely as other patients to enroll in evidence-based tobacco cessation treatment when it was offered in the context of a primary care visit. Cessation outcomes were also comparable. Therefore, standard care for PLWH should include routine screening for smoking status and referrals to cessation treatment.
Authors: Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read Journal: Am J Public Health Date: 2010-08-19 Impact factor: 9.308
Authors: Kristina Crothers; Tephany A Griffith; Kathleen A McGinnis; Maria C Rodriguez-Barradas; David A Leaf; Sharon Weissman; Cynthia L Gibert; Adeel A Butt; Amy C Justice Journal: J Gen Intern Med Date: 2005-12 Impact factor: 5.128
Authors: Joseph G Feldman; Howard Minkoff; Michael F Schneider; Stephen J Gange; Mardge Cohen; D Heather Watts; Monica Gandhi; Robert S Mocharnuk; Kathryn Anastos Journal: Am J Public Health Date: 2006-05-02 Impact factor: 9.308
Authors: Jennifer Irvin Vidrine; Sanjay Shete; Yisheng Li; Yumei Cao; Margo Hilliard Alford; Michelle Galindo-Talton; Vance Rabius; Barry Sharp; Penny Harmonson; Susan M Zbikowski; Lyndsay Miles; David W Wetter Journal: Am J Prev Med Date: 2013-12 Impact factor: 5.043
Authors: Bárbara Piñeiro; Damon J Vidrine; David W Wetter; Diana S Hoover; Summer G Frank-Pearce; Nga Nguyen; Susan M Zbikowski; Jennifer I Vidrine Journal: Transl Behav Med Date: 2020-02-03 Impact factor: 3.046
Authors: Damon J Vidrine; Thanh C Bui; Michael S Businelle; Ya-Chen Tina Shih; Steven K Sutton; Lokesh Shahani; Diana Stewart Hoover; Kristina Bowles; Jennifer I Vidrine Journal: JMIR Res Protoc Date: 2021-11-17
Authors: Jennifer I Vidrine; Ya-Chen Tina Shih; Michael S Businelle; Steven K Sutton; Diana Stewart Hoover; Cherell Cottrell-Daniels; Bethany Shorey Fennell; Kristina E Bowles; Damon J Vidrine Journal: BMC Public Health Date: 2022-03-22 Impact factor: 4.135